{
    "code": "02024275",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024275",
    "time": "2021-11-19 05:26:43",
    "許可證字號": "衛署藥輸字第024275號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/07\/27",
    "發證\/登錄日期": "94\/07\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202427502",
    "中文品名": "利憶靈持續性藥效膠囊8毫克",
    "英文品名": "REMINYL PROLONGED RELEASE CAPSULES 8MG",
    "適應症": "治療ALZHEIMER症輕度至中度嚴重失智症",
    "劑型": "133持續性藥效膠囊劑",
    "包裝": "2-1000粒鋁箔盒裝 2-1000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GALANTAMINE HYDROBROMIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FBE0079000  JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "LAMMERDRIES 55 2250 OLEN, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "半成品(BULK MICROSPHERE)"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200042310",
            "成分名稱": "GALANTAMINE HYDROBROMIDE",
            "含量描述": "",
            "含量": "10.2500000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Reminyl 8mg PR capsule外觀-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件3_[打樣版] Reminyl PR Cap 8, 16mg_CCDS 23Oct2020_v2101-110-09-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=024&Type=9"
        },
        {
            "title": "Reminyl PR Cap 8mg photo_20201103-109-11-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=014&Type=8"
        },
        {
            "title": "Reminyl 8mg PR CSP 外觀-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=013&Type=8"
        },
        {
            "title": "Reminyl PR Cap 8mg-foil-105-12-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024275&Seq=011&Type=8"
        }
    ]
}